Literature DB >> 3721580

Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.

E V Oaks, T L Hale, S B Formal.   

Abstract

The serum antibody response to proteins encoded by the virulence-associated plasmid of Shigella flexneri was determined in monkeys challenged with virulent S. flexneri serotype 2a. With water-extractable antigen in an enzyme-linked immunosorbent assay, a significant increase in antibody titer against proteins from a plasmid-carrying, virulent strain of S. flexneri serotype 5 could be demonstrated in convalescent sera. There were minimal antibody titers against proteins from an avirulent (plasmid-free) organism. Previously identified plasmid-coded polypeptides a, b, c, and d were predominant antigens recognized by a majority of the convalescent sera in immunoblots. An additional 140-megadalton plasmid-coded polypeptide was also recognized by half of the sera. Convalescent serum from an infected monkey recognized antigens on the bacterial surface in several different plasmid-containing Shigella species and in an enteroinvasive Escherichia coli strain. A survey of sera obtained from children 5 to 10 years of age who had been infected with S. flexneri or S. sonnei revealed high enzyme-linked immunosorbent assay titers in both acute and convalescent sera against a water extract from a virulent Shigella strain. In contrast, children under 3 years of age had no antibody titer in either acute or convalescent sera against the virulence-associated shigella proteins, while 3- to 4-year-old children mounted an immune response against these proteins only in convalescence.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3721580      PMCID: PMC260075          DOI: 10.1128/iai.53.1.57-63.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).

Authors:  T Meitert; E Pencu; L Ciudin; M Tonciu
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1984 Jul-Dec

4.  Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.

Authors:  S B Formal; T L Hale; C Kapfer; J P Cogan; P J Snoy; R Chung; M E Wingfield; B L Elisberg; L S Baron
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

5.  Isolation of species-specific protein antigens of Rickettsia typhi and Rickettsia prowazekii for immunodiagnosis and immunoprophylaxis.

Authors:  G A Dasch
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

6.  Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen.

Authors:  D J Kopecko; O Washington; S B Formal
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

7.  Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.

Authors:  D M Mel; A L Terzin; L Vuksić
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

8.  ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.

Authors:  S B FORMAL; E H LABREC; T H KENT; S FALKOW
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

9.  Shigella sonnei phase I and phase II: susceptibility to direct serum lysis and opsonic requirements necessary for stimulation of leukocyte redox metabolism and killing.

Authors:  G S Madonna; R C Allen
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Involvement of a plasmid in the invasive ability of Shigella flexneri.

Authors:  P J Sansonetti; D J Kopecko; S B Formal
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

View more
  87 in total

1.  Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B.

Authors:  E V Oaks; K R Turbyfill
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

2.  virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence.

Authors:  M C Lett; C Sasakawa; N Okada; T Sakai; S Makino; M Yamada; K Komatsu; M Yoshikawa
Journal:  J Bacteriol       Date:  1989-01       Impact factor: 3.490

3.  Two novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion of invasion plasmid antigens.

Authors:  G P Andrews; A E Hromockyj; C Coker; A T Maurelli
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 4.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

Review 5.  Genetic basis of virulence in Shigella species.

Authors:  T L Hale
Journal:  Microbiol Rev       Date:  1991-06

6.  Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.

Authors:  Sekar Tamil Selvi Chitradevi; Gurpreet Kaur; Sivaramakrishna Uppalapati; Anandprakash Yadav; Dependrapratap Singh; Anju Bansal
Journal:  Cell Mol Immunol       Date:  2015-02-02       Impact factor: 11.530

7.  Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T.

Authors:  Amy V Jennison; Rubhana Raqib; Naresh K Verma
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Increased protein secretion and adherence to HeLa cells by Shigella spp. following growth in the presence of bile salts.

Authors:  L M Pope; K E Reed; S M Payne
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.

Authors:  Anuradha Sinha; Ayan Dey; Giulietta Saletti; Pradip Samanta; Partha Sarathi Chakraborty; M K Bhattacharya; Santanu Ghosh; T Ramamurthy; Jae-Ouk Kim; Jae Seung Yang; Dong Wook Kim; Cecil Czerkinsky; Ranjan K Nandy
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

Review 10.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.